Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE012 (BRA) (Dr. Kowalski)
· consented 2023-01-11
Adverse events
3
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Grade 2 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-03-15 (study day 43); relationship: Y
severe
serious
assessed
2026-08-18
Grade 4 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-12-12 (study day 315); relationship: not assessed; serious criteria: life-threatening
moderate
assessed
2026-08-18
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2024-06-12 (study day 498); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.